As part of Roche’s work to put the patient voice at the forefront of health technology assessments (HTAs), Melanoma UK has been invited to attend the launch of the report: A review of patient involvement in HTAs

In 2018 Roche held a briefing session with patient groups on the HTA process and heard there were still areas where patient involvement could be improved.  To better understand this, Roche commissioned Costello Medical Consultancy to conduct a literature review on the topic and an in-depth analysis of ten NICE technology appraisals. 

The report sets out the findings of this research and identifies principles we believe national bodies, patient groups, and industry can work towards in partnership to improve patient involvement in HTAs. 

Costello Medical will present the report followed by a panel discussion with representatives from NICE.

An update will follow.